Scarica l'app Stockscreener
10.50
32.82%
-5.13
Dopo l'orario di chiusura:
10.29
-0.21
-2.00%
Precedente Chiudi:
$15.63
Aprire:
$9.19
Volume 24 ore:
16.76M
Relative Volume:
6.18
Capitalizzazione di mercato:
$654.06M
Reddito:
$15.75M
Utile/perdita netta:
$-235.15M
Rapporto P/E:
-2.394
EPS:
-4.386
Flusso di cassa netto:
$-154.09M
1 W Prestazione:
-57.08%
1M Prestazione:
-57.49%
6M Prestazione:
-38.27%
1 anno Prestazione:
-20.15%
Intervallo 1D:
$8.96
$11.09
Intervallo di 1 settimana:
$8.96
$25.13
Portata 52W:
$7.76
$71.50
Uniqure N V Stock (QURE) Company Profile
Nome
Uniqure N V
Settore
Industria
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Compare QURE vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
10.50 | 973.62M | 15.75M | -235.15M | -154.09M | -4.386 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-28 | Iniziato | Barclays | Equal Weight |
| 2025-11-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-04-01 | Ripresa | Chardan Capital Markets | Buy |
| 2024-12-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-02-29 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-19 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-17 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-11-09 | Iniziato | Jefferies | Buy |
| 2020-11-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-08-25 | Iniziato | Raymond James | Strong Buy |
| 2020-07-31 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Downgrade | Mizuho | Buy → Neutral |
| 2020-06-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Iniziato | Cowen | Outperform |
| 2019-12-03 | Iniziato | Goldman | Buy |
| 2019-11-05 | Iniziato | Credit Suisse | Outperform |
| 2019-10-11 | Iniziato | Stifel | Buy |
| 2019-09-25 | Iniziato | Bernstein | Outperform |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-07-30 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-07-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-03-29 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Uniqure N V Borsa (QURE) Ultime notizie
QURE INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - Morningstar
uniQure (QURE) Shares Affected by FDA Commentary - GuruFocus
Stifel comments on uniQure shares after FDA commissioner remarks By Investing.com - Investing.com India
uniQure (QURE) Faces Investor Concerns Amid FDA Commentary - GuruFocus
uniQure (NASDAQ:QURE) Shares Gap DownShould You Sell? - MarketBeat
uniQure down on FDA chief's comments (update) (QURE:NASDAQ) - Seeking Alpha
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors - GlobeNewswire
uniQure (QURE) Shares Plunge as FDA Casts Doubt on AMT-130 Approval - GuruFocus
uniQure N.V. Stock Alert: QURE Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses - PR Newswire
UniQure stock tumbles on FDA comments about gene therapy trial - Investing.com
INVESTOR REMINDER: Berger Montague Notifies uniQure N.V. (QURE) Investors of a Class Action Lawsuit and Deadline - marketscreener.com
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of ... - Bluefield Daily Telegraph
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. ... - Bluefield Daily Telegraph
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm - GlobeNewswire Inc.
QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 (2026-02-25) - Seeking Alpha
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler - GlobeNewswire
UNIQURE N.V. (QURE) DEADLINE ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline - ACCESS Newswire
uniQure N.V. $QURE Shares Sold by JPMorgan Chase & Co. - MarketBeat
uniQure N.V. Securities Fraud Class Action Result of FDA - GlobeNewswire
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - GlobeNewswire Inc.
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - GlobeNewswire Inc.
QURE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages QURE Investors with Losses to Contact the Firm - PR Newswire
QURE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - TMX Newsfile
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
The Gross Law Firm Reminds uniQure Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026QURE - Morningstar
Wolfe Research Initiates Coverage on uniQure (QURE) with 'Peer P - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Wolfe Research Initiates Coverage of uniQure N.V. (QURE) with Peer Perform Recommendation - Nasdaq
5 Analysts Assess uniQure: What You Need To Know - Benzinga
Holzer & Holzer, LLC Reminds QURE Investors of the April - GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages uniQure N.V. - GlobeNewswire
Shareholders that lost money on uniQure N.V.(QURE) Urged to - GlobeNewswire
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action LawsuitContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Quarterly Risk: Can uniQure NV continue delivering strong returns - baoquankhu1.vn
uniQure to Announce 2025 Financial Results - The Manila Times
uniQure N.V. to Report Q4 and Full Year 2025 Financial Results on March 2, 2026 - Quiver Quantitative
UniQure N.V. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsQURE - marketscreener.com
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit – Company Announcement - Financial Times
User - The Chronicle-Journal
QURE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
uniQure (NASDAQ:QURE) Stock Price Down 5.8% – Should You Sell? - Defense World
Will uniQure N.V. stock recover faster than marketPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - mfd.ru
Avoro Capital Advisors LLC Increases Stake in uniQure NV - GuruFocus
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - Sahm
RTW INVESTMENTS, LP Reduces Stake in uniQure NV - GuruFocus
Uniqure N V Azioni (QURE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.90%
2.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):